Image

TOUCH® CMC 1 New Enrollment US Study

TOUCH® CMC 1 New Enrollment US Study

Recruiting
22 years and older
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to meet a PMA (P240020) condition of approval of the TOUCH® CMC 1 Prosthesis to evaluate the effectiveness and safety of the prosthesis in the United States (US) population. The device performance in newly enrolled US patients implanted by US surgeons will be compared to device performance observed within the outside the US (OUS) premarket cohort.

Description

TOUCH® CMC 1 (Carpometacarpal) Prosthesis is a cementless, ball-and-socket dual-mobility, total CMC1 joint replacement prosthesis, designed to treat osteoarthritis of the base of the thumb. The TOUCH® CMC 1 Prosthesis was approved by FDA (P240020) on July 10, 2025. Continued approval of the premarket approval application (PMA) is contingent upon the submission of periodic reports (Annual Report), required under 21 CFR 814.84. In order to provide continued reasonable assurance of the safety and effectiveness of the PMA device, data from this post-approval study must be submitted to FDA in a PMA Post Approval Study Report per the requirements set forth in the approval.

Eligibility

Inclusion Criteria:

  1. Patient requiring 1st carpometacarpal (CMC) primary total joint replacement (arthroplasty) to surgically treat symptomatic Eaton-Littler Stage II or III osteoarthritis (OA)
  2. Adult (≥ 22 years of age) at the time of enrollment
  3. Willing and able to sign the study Informed Consent

Exclusion Criteria:

  1. Acute or chronic infections, local or systemic
  2. Muscular, neurological, or vascular severe deficiency affecting the joint
  3. Inadequate bone quality or quantity preventing the implant fixation
  4. Bones dimensions incompatible with implant sizes
  5. Patients who are allergic to the product's materials
  6. Any concomitant disorder that may affect the function of the implant (e.g., osteoarthritis of the wrist)
  7. Skeletally immature (i.e., pediatric population, \<22 years of age)
  8. Pregnant or nursing women
  9. Patients with contraindications to surgery in general
  10. Patients with an intellectual disability who cannot follow the instructions of their surgeon.

Study details
    Osteoarthritis Thumb
    Thumb Carpometacarpal Joint Osteoarthritis

NCT07405983

Keri Medical SA

27 June 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.